Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Medicine (Baltimore). 2013 Jul;92(4):223–243. doi: 10.1097/MD.0b013e31829d08f9

Table 13.

Characteristics of juvenile myositis classic autoantibody phenotypes

Characteristic Anti-Synthetase Anti-SRP Anti-Mi-2
Demographics
 Median age at diagnosis (y) Older (14.0 years) Oldest (15.1 years) Older (11.0 years)
 Race Larger proportion non-white (47%) Larger proportion of black patients (83%) Larger proportion of non-white
(82%) - mostly Hispanic
 Severity of onset No penchant Severe or very severe (100%) Mild or moderate severity (61%)
 Delay in diagnosis Shorter delay to diagnosis (1.9 months)
 Clinical group JDM (53%), JPM (16%), or JCTM (32%) JPM JDM (JDM or JDM overlap)
Clinical Features Arthralgia Distal weakness Gottron’s papules
“Mechanic’s” hands Falling episodes Heliotrope rash
Interstitial lung disease Raynaud’s phenomenon Malar rash
Arthritis Muscle atrophy
Raynaud’s phenomenon Abnormal EKG or ECHO
Sclerodactyly Dysphonia
Dyspnea at rest or on exertion Dyspnea on exertion
Abnormal PFTs Abnormal PFTs
Chest pain
Fever
Weight loss
Laboratory Features Intermediate CK levels (median 3409 units/L) Highest CK level (median 18544 units/L) High CK level (median 15926
units/L)
Intermediate levels of aldolase, LDH, AST, ALT Highest levels of aldolase, LDH, AST, ALT High levels of aldolase, LDH, AST, ALT
Intermediate % with positive ANA (39%) ANA negative ANA positive (100%)
Intermediate ANA titers (median 1:320) Highest ANA titers (median 1:1280)
Outcome Highest mortality (16.7%)
Lower percentage with calcinosis (10%) Chronic disease course (100%)
Hospitalized (100%)
Wheelchair use (83.3%)

Abbreviations: SRP = signal recognition particle; JDM = juvenile dermatomyositis; JPM = juvenile polymyositis; JCTM = juvenile myositis overlapping with another autoimmune or connective tissue disease; EKG = electrocardiogram; ECHO = echocardiogram; PFT = pulmonary function test

CK = creatine kinase; LDH = lactate dehydrogenase; AST = aspartate aminotransferase; ALT = alanine aminotransferase; ANA = anti-nuclear antibody.

Bold = significant in logistic regression or universally present in the group; Italicized indicates top variables from random forest models. Other variables included in this table were significant in univariable analysis. Note that random forest modeling was not performed in patients with anti-SRP and anti-Mi-2 autoantibodies.